Position in PBLS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,343
New position
Shares Held
451
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#67
of 79 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $389,495 across 65 Biotechnology names. PBLS ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
150 | $74,509 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,446 | $51,173 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
112 | $20,975 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 5 | ARGX |
Argenx SE
|
20 | $18,555 | |
| 6 | INCY |
Incyte Corp
|
156 | $17,684 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
223 | $16,609 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49 | $14,750 |
All Filings in PBLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,343 | 451 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||